NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Zageno

Zageno

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://zageno.com/

Last Round

Series C

May 25, 2023

Total Funding Raised

$121M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Zageno is a life sciences company that operates an AI-powered marketplace designed to streamline the procurement of research materials for scientists and procurement teams.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Vertical SaaS, E-commerce

Business Model

B2B

Customer Profile

Marketplace Commission, Subscription SaaS

AI Layer

Application

Keywords

e-procurementlife science procurementB2B marketplacespend managementscientific supplieslab procurementvertical SaaSERP integrationprocure-to-payenterprise resource planningERPsupply chain managementlab operationsprocurement automationpharma supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zageno Comparables

Compare Zageno with similar companies based on industry and business-model similarity.

Zageno comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Labviva
93%
Quartzy
88%
BioProcure
84%

Zageno Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 25, 2023
Series CNov 16, 2021
Series BApr 23, 2019
Series AOct 25, 2017

Key People

Founding team and executive leadership

Florian Wegener

CEO & Co-Founder

Founding Team

Konstantinos Sereleas

COO

Executive Team

David Pumberger

Chief Strategy Innovation Officer, Chief Product Officer

Executive Team

Zageno Investors

Notable investors and investment history

Zageno investors
InvestorRounds
Oak Ridge Management GroupSeries C
HighSage VenturesSeries C
General CatalystSeries C, Series B
Capnamic VenturesSeries C, Series B, Series A
Grazia EquitySeries C, Series A, Series B, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 8, 2026

    Added nEureka®, a biotechnology SMB, as a customer.

  • Mar 8, 2026

    Added Apogee Therapeutics, a biotechnology company, as a customer.

Zageno Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zageno Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zageno's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range126
Year Founded2015
Last FundingMay 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.